SOURCE: Leerink Swann

May 07, 2007 09:00 ET

Joseph Gentile Joins Leerink Swann as Chief Administrative Officer (CAO)

BOSTON, MA -- (MARKET WIRE) -- May 7, 2007 -- Healthcare investment bank Leerink Swann announced Joseph Gentile joined the firm as Chief Administrative Officer (CAO). In his position, Mr. Gentile will lead the strategic financial planning and fiscal management of the firm.

"I am pleased to welcome Joe Gentile to the firm," said Jeffrey A. Leerink, Chairman and CEO of Leerink Swann. "We are extremely fortunate to have someone of Joe's caliber and outstanding credentials direct the financial strategy of the firm. Over a 20-year career, Joe has consistently delivered stellar financial management performance with some of the finest firms on Wall Street.

"With our focus on healthcare and the proprietary insights generated from MEDACorp, our expert healthcare network, we are uniquely positioned to take advantage of many growth opportunities. The strategic depth that Joe brings to this role will help the firm execute on these opportunities."

Mr. Gentile was formerly CFO, Global Investment Bank at Lehman Brothers, where he directed the accounting and financial needs within the Fixed Income division, the largest operating division of Lehman Brothers.

Prior to that, he served as CFO of the Global Corporate and Investment Bank at Bank of America, where he led the Capital Markets Division. Previously, Mr. Gentile spent more than 10 years with J.P. Morgan in various financial management positions, including Global Head of Financial Risk Management. He holds a B.A. cum laude and M.B.A. magna cum laude from St. John's University.

"By focusing their resources exclusively on healthcare, Leerink Swann has successfully built a differentiated model for investment banking," stated Joe Gentile. "They have earned a reputation in healthcare that distinguishes them from traditional investment banks. I look forward to working with their outstanding team to expand the firm's position as the premier healthcare investment bank on Wall Street."

About Leerink Swann

Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, asset management, and strategic advisory services for institutional, life sciences, and high-net-worth clients. For the past six years, Institutional Investor has named Leerink Swann "Best of the Boutiques" in Biotechnology, Healthcare Technology & Distribution, Medical Supplies and Devices, Pharmaceuticals/Major, and Pharmaceuticals/Specialty. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member NASD/SIPC.

Contact Information